Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin-dependent kinase inhibitors

Chronic lymphocytic leukemia (CLL) treatment is improving; however, some patients do not respond to therapy. Due to the high heterogeneity in disease development, there is an urgent need for personalization of therapy. In the present study, the response of leukemic mononuclear cells to anticancer dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubczak, Małgorzata, Szustka, Aleksandra, Błoński, Jerzy Z., Gucký, Tomaš, Misiewicz, Małgorzata, Krystof, Vladmir, Robak, Paweł, Rogalińska, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470834/
https://www.ncbi.nlm.nih.gov/pubmed/30864706
http://dx.doi.org/10.3892/mmr.2019.10007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470834/
https://www.ncbi.nlm.nih.gov/pubmed/30864706
http://dx.doi.org/10.3892/mmr.2019.10007

Ejemplares similares